232 related articles for article (PubMed ID: 9600576)
1. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.
Stevens KE; Kem WR; Mahnir VM; Freedman R
Psychopharmacology (Berl); 1998 Apr; 136(4):320-7. PubMed ID: 9600576
[TBL] [Abstract][Full Text] [Related]
2. Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice.
Simosky JK; Stevens KE; Kem WR; Freedman R
Biol Psychiatry; 2001 Oct; 50(7):493-500. PubMed ID: 11600102
[TBL] [Abstract][Full Text] [Related]
3. Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats.
Callahan PM; Terry AV; Tehim A
Psychopharmacology (Berl); 2014 Sep; 231(18):3695-706. PubMed ID: 24595504
[TBL] [Abstract][Full Text] [Related]
4. Continuous administration of a selective alpha7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice.
Stevens KE; Cornejo B; Adams CE; Zheng L; Yonchek J; Hoffman KL; Christians U; Kem WR
Brain Res; 2010 Sep; 1352():140-6. PubMed ID: 20599427
[TBL] [Abstract][Full Text] [Related]
5. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.
Kem WR; Mahnir VM; Papke RL; Lingle CJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
Meyer EM; Kuryatov A; Gerzanich V; Lindstrom J; Papke RL
J Pharmacol Exp Ther; 1998 Dec; 287(3):918-25. PubMed ID: 9864273
[TBL] [Abstract][Full Text] [Related]
7. The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?
Olivier B; Leahy C; Mullen T; Paylor R; Groppi VE; Sarnyai Z; Brunner D
Psychopharmacology (Berl); 2001 Jul; 156(2-3):284-90. PubMed ID: 11549230
[TBL] [Abstract][Full Text] [Related]
8. alpha7 receptor-selective agonists and modes of alpha7 receptor activation.
Papke RL; Meyer E; Nutter T; Uteshev VV
Eur J Pharmacol; 2000 Mar; 393(1-3):179-95. PubMed ID: 10771012
[TBL] [Abstract][Full Text] [Related]
9. GTS-21, a mixed nicotinic receptor agonist/antagonist, does not affect the nicotine cue.
van Haaren F; Anderson KG; Haworth SC; Kem WR
Pharmacol Biochem Behav; 1999 Oct; 64(2):439-44. PubMed ID: 10515327
[TBL] [Abstract][Full Text] [Related]
10. Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine.
Papke RL; Kem WR; Soti F; López-Hernández GY; Horenstein NA
J Pharmacol Exp Ther; 2009 May; 329(2):791-807. PubMed ID: 19223664
[TBL] [Abstract][Full Text] [Related]
11. Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors.
Uteshev VV; Meyer EM; Papke RL
Brain Res; 2002 Sep; 948(1-2):33-46. PubMed ID: 12383953
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic agonist modulation of neurotransmitter levels in the rat frontoparietal cortex.
Summers KL; Kem WR; Giacobini E
Jpn J Pharmacol; 1997 Jun; 74(2):139-46. PubMed ID: 9243321
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice.
Wildeboer KM; Stevens KE
Brain Res; 2008 Aug; 1224():29-36. PubMed ID: 18582447
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.
Papke RL; Porter Papke JK
Br J Pharmacol; 2002 Sep; 137(1):49-61. PubMed ID: 12183330
[TBL] [Abstract][Full Text] [Related]
15. Positive modulation of alpha7 nAChR responses in rat hippocampal interneurons to full agonists and the alpha7-selective partial agonists, 4OH-GTS-21 and S 24795.
López-Hernández GY; Thinschmidt JS; Morain P; Trocme-Thibierge C; Kem WR; Soti F; Papke RL
Neuropharmacology; 2009 Mar; 56(4):821-30. PubMed ID: 19705574
[TBL] [Abstract][Full Text] [Related]
16. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).
Kem WR
Behav Brain Res; 2000 Aug; 113(1-2):169-81. PubMed ID: 10942043
[TBL] [Abstract][Full Text] [Related]
17. The structural basis for GTS-21 selectivity between human and rat nicotinic alpha7 receptors.
Stokes C; Papke JK; Horenstein NA; Kem WR; McCormack TJ; Papke RL
Mol Pharmacol; 2004 Jul; 66(1):14-24. PubMed ID: 15213292
[TBL] [Abstract][Full Text] [Related]
18. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.
Martin LF; Kem WR; Freedman R
Psychopharmacology (Berl); 2004 Jun; 174(1):54-64. PubMed ID: 15205879
[TBL] [Abstract][Full Text] [Related]
19. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia.
Mastropaolo J; Rosse RB; Deutsch SI
Behav Brain Res; 2004 Aug; 153(2):419-22. PubMed ID: 15265637
[TBL] [Abstract][Full Text] [Related]
20. α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.
Kox M; Pompe JC; Peters E; Vaneker M; van der Laak JW; van der Hoeven JG; Scheffer GJ; Hoedemaekers CW; Pickkers P
Br J Anaesth; 2011 Oct; 107(4):559-66. PubMed ID: 21771746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
